Similarly, comparing CSF cytokine/chemokine elevations in aggressive osteosarcoma and ALL models following tumor-clearing CAR T cell therapy here, many shared but also some distinct changes are observed, such as elevated CCL7 and BAFF in the ALL model but not the aggressive osteosarcoma model. The gene discussed is TNFSF13B; the disease is neoplasm.